May 21, 2021
NABP to FDA: Delay the MOU enforcement
NABP has written to FDA, adding its voice to that of APC and others and requesting delay of enforcement on the interstate-shipment MOU.
Several states have indicated that regulatory changes, which involve lengthy processes and require extensive public comment periods, are needed. Others have indicated that statutory amendments are necessary, and the legislatures are placing a great deal of focus on COVID-19-related legislation.
